Summary
The University of Melbourne is an educational service provider that offers graduate, postgraduate, and research degrees. The university offers education in various fields which include arts, engineering, business and economics, architecture, building and planning, land and environment, medical, dentistry, information and technology, education, and health science, law, veterinary science, among others. It also offers awareness and management services to the society in the field of research and teaching services. The university's health services comprise contraception, sexually transmitted infections, women's health, men's health, and others. It also offers research programs. The University of Melbourne is headquartered in Parkville, Victoria, Australia.
The University of Melbourne - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
The University of Melbourne, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
The University of Melbourne, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
The University of Melbourne, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
The University of Melbourne, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
The University of Melbourne, Medical Devices Deals, 2011 to YTD 2017 9
The University of Melbourne, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
The University of Melbourne, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Hatchtech Raises US$12 Million In Venture Financing 12
Hatchtech Raises US$6.3 Million In Venture Financing 13
Partnerships 14
University of Melbourne Enters Into Agreement With Procypra To Develop Drugs For Neurological Diseases 14
Peter MacCallum Cancer Centre Enters Into Licensing Agreement With GenoLogics Life Sciences Software For Clarity LIMS 15
International Stem Cell Enters into Research Agreement with Florey Institute of Neuroscience and Mental Health 16
Servier Enters into Research Agreement with Walter and Eliza Hall Institute of Medical Research 17
Sanofi Pasteur Enters into Agreement with University of Melbourne to Develop Human Vaccines 18
Janssen-Cilag Enters Into Research Agreement With University of Melbourne 19
Servier Enters Into R&D Agreement With Florey Institute of Neuroscience and Mental Health 20
Molecular Discovery Enters Into Co Development Agreement With Peter MacCallum Cancer Centre 22
ImmusanT Enters Into Research Agreement With Walter and Eliza Hall Institute of Medical Research 23
Western Health Forms Joint Venture With Peter MacCallum Cancer Centre 24
Licensing Agreements 25
TetraLogic Pharma Enters Into Licensing Agreement With Walter And Eliza Hall Institute Of Medical Research 25
The University of Melbourne - Key Competitors 26
The University of Melbourne - Key Employees 27
The University of Melbourne - Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Joint Venture 29
Recent Developments 30
Strategy And Business Planning 30
Mar 07, 2016: Expanded Bio21 to house global research hub 30
Government and Public Interest 31
Apr 14, 2016: New hope for malaria treatment as drug resistance found unable to spread for the first time 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32
List of Tables
The University of Melbourne, Pharmaceuticals & Healthcare, Key Facts 2
The University of Melbourne, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
The University of Melbourne, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
The University of Melbourne, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
The University of Melbourne, Deals By Therapy Area, 2011 to YTD 2017 8
The University of Melbourne, Medical Devices Deals, 2011 to YTD 2017 9
The University of Melbourne, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Hatchtech Raises US$12 Million In Venture Financing 12
Hatchtech Raises US$6.3 Million In Venture Financing 13
University of Melbourne Enters Into Agreement With Procypra To Develop Drugs For Neurological Diseases 14
Peter MacCallum Cancer Centre Enters Into Licensing Agreement With GenoLogics Life Sciences Software For Clarity LIMS 15
International Stem Cell Enters into Research Agreement with Florey Institute of Neuroscience and Mental Health 16
Servier Enters into Research Agreement with Walter and Eliza Hall Institute of Medical Research 17
Sanofi Pasteur Enters into Agreement with University of Melbourne to Develop Human Vaccines 18
Janssen-Cilag Enters Into Research Agreement With University of Melbourne 19
Servier Enters Into R&D Agreement With Florey Institute of Neuroscience and Mental Health 20
Molecular Discovery Enters Into Co Development Agreement With Peter MacCallum Cancer Centre 22
ImmusanT Enters Into Research Agreement With Walter and Eliza Hall Institute of Medical Research 23
Western Health Forms Joint Venture With Peter MacCallum Cancer Centre 24
TetraLogic Pharma Enters Into Licensing Agreement With Walter And Eliza Hall Institute Of Medical Research 25
The University of Melbourne, Key Competitors 26
The University of Melbourne, Key Employees 27
The University of Melbourne, Other Locations 28
The University of Melbourne, Subsidiaries 28
The University of Melbourne, Joint Venture 29
List of Figures
The University of Melbourne, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
The University of Melbourne, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
The University of Melbourne, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
The University of Melbourne, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
The University of Melbourne, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
The University of Melbourne, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
The University of Melbourne, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
The University of Melbourne, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
The University of Melbourne, Medical Devices Deals, 2011 to YTD 2017 9
